KINERET Dosage & Rx Info | Uses, Side Effects
KINERET® (anakinra) Official HCP Website | Dosing Calculator
Frontiers | Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants
Cancers | Free Full-Text | Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry | The Journal of Rheumatology
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review - Charlesworth - European Journal of Haematology - Wiley Online Library
2019 Clinical Guidelines Template
Anakinra for Gout Flares: Is There a Role? | MedPage Today
Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study | Clinical Rheumatology
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial | Nature Medicine
IJMS | Free Full-Text | Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
Frontiers | Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
Kineret Subcutaneous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS) | Journal for ImmunoTherapy of Cancer
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society for ...
Frontiers | Anakinra Therapy for Non-cancer Inflammatory Diseases
Clinical Commissioning Policy: Anakinra for Haemophagocytic Lymphohistiocytosis (HLH) for adults and children in all ages [21070
Reference ID: 3933625
Current evidence on the use of anakinra in COVID-19 - ScienceDirect
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes | BMC Pharmacology and Toxicology | Full Text
KINERET® (anakinra) Official Website | Using KINERET for NOMID
Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study | Clinical Rheumatology
Kineret, INN-anakinra
A randomized controlled pilot trial of anakinra for hemodialysis inflammation - Kidney International
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis - Bami - 2020 - Pediatric Blood & Cancer - Wiley Online Library
Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease: when dosage matters in overcoming secondary therapy resistance - Sofia Ajeganova, Ann De Becker, Rik Schots, 2020
KINERET® (anakinra) Official HCP Website | Dosing and Administration
